Managlay, Merry-an .

HRN: 07-90-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFTRIAXONE 1G (VIAL)
09/28/2025
10/05/2025
IV
2g
OD
T/c H Mole; T/c CAP-MR
Checking Initial Appropriateness 
09/29/2025
MUPIROCIN 2%, 15G (TUBE)
09/29/2025
10/06/2025
SKIN
2%
BID
Lesions On Skin
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: